Vnitr Lek 2024, 70(7):438-444 | DOI: 10.36290/vnl.2024.086

Intermittently scanned continuous glucose monitoring (isCGM) in hospitalized elderly patients

Darina Matvějeva, Martina Nováková, Pavlína Piťhová, Lucie Tománková, Vladimíra Kotvová, Daniela Polanecká, Milan Kvapil
Geriatrická interní klinika 2. LF UK a FN Motol, Praha

The prevalence of internal diseases increasing with age is the reason for the increased number of seniors among those hospitalized in non-surgical beds. The disease that is the reason for hospitalization in a patient with diabetes usually fluctuates blood sugar. A number of examination methods require preparation with a change in intake and diet composition, a certain period of fasting before or after the procedure. All this increases the risk of hypo/hyperglycemia. It threatens the health and life of the patient. Prevention is especially frequent monitoring of blood glucose. Despite the advanced development of collection and measurement of glucose in capillary blood, continuous glucose measurement with a sensor appears to be a possible positive alternative. Therefore, immediately after the GIK beds were put into operation, we took advantage of the possibilities offered by Intermittently Scanned Continuous Glycemic Measurement (isCGM). Our first experiences with the use of isCGM in elderly patients hospitalized at GIK are very positive. When implementing the method, it was a surprising finding that there is not much data available in the scientific literature evaluating the benefits/risks of isCGM during routine non-ICU hospitalization in patients requiring frequent glycemic monitoring.

Keywords: intermittently scanned continuous glucose monitoring; is-CGM; in patiens; diabetes mellitus.

Accepted: October 24, 2024; Published: November 14, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matvějeva D, Nováková M, Piťhová P, Tománková L, Kotvová V, Polanecká D, Kvapil M. Intermittently scanned continuous glucose monitoring (isCGM) in hospitalized elderly patients. Vnitr Lek. 2024;70(7):438-444. doi: 10.36290/vnl.2024.086.
Download citation

References

  1. Kvapil M. ed. Diabetologie 2023. Triton, Praha.
  2. Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care. 2018 Nov;41(11):2275-2280. Go to original source... Go to PubMed...
  3. Beck RW, Connor CG, Mullen DM, et al. The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading. Diabetes Care. 2017 Aug;40(8):994-999. Go to original source... Go to PubMed...
  4. Perlman JE, Gooley TA, McNulty B, et al. HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis. Diabetes Technol Ther. 2021 Apr;23(4):253-258. Go to original source... Go to PubMed...
  5. Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. Go to original source... Go to PubMed...
  6. Chalew SA, McCarter RJ, Thomas J, et al. A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes. J Diabetes Complications. 2005 Jul-Aug;19(4):218-22 Go to original source... Go to PubMed...
  7. Soros AA, Chalew SA, McCarter RJ, et al. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes. 2010 Nov;11(7):455-61. Go to original source... Go to PubMed...
  8. Hempe JM, Hsia DS. Variation in the hemoglobin glycation index. J Diabetes Complications. 2022 Jul;36(7):108223 Go to original source... Go to PubMed...
  9. Ogrin R, Aylen T, Thurgood L, Neoh SL, Audehm R, Steel P, Churilov L, Zajac J, Ekinci EI. Older People With Type 2 Diabetes-Individualising Management With a Specialised Community Team (OPTIMISE): Perspectives of Participants on Care. Clin Diabetes. 2021 Oct;39(4):397-410. Go to original source... Go to PubMed...
  10. Leelarathna L, Evans ML, Neupane S, FLASH-UK Trial Study Group. Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes. N Engl J Med. 2022 Oct 20;387(16):1477-1487. Go to original source... Go to PubMed...
  11. Carlson AL, Daniel TD, DeSantis A, et al. Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis. BMJ Open Diabetes Res Care. 2022 Jan;10(1):e002590. Go to original source... Go to PubMed...
  12. Ajjan RA, Heller SR, Everett CC, et al. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial. Diabetes Care. 2023 Feb 1;46(2):441-449. Go to original source... Go to PubMed...
  13. Denham D. A Head-to-Head Comparison Study of the First-Day Performance of Two Factory-Calibrated CGM Systems. J Diabetes Sci Technol. 2020 Mar;14(2):493-495. Go to original source... Go to PubMed...
  14. Price C, Ditton G, Russell GB, Aloi J. Reliability of Inpatient CGM: Comparison to Standard of Care. J Diabetes Sci Technol. 2023 Mar;17(2):329-335. Go to original source... Go to PubMed...
  15. Spierling Bagsic SR, Fortmann AL, Belasco R, et al. Real-Time Continuous Glucose Monitoring in the Hospital: A Real-World Experience. J Diabetes Sci Technol. 2023 May;17(3):656-666. Go to original source... Go to PubMed...
  16. Rigon FA, Ronsoni MF, Vianna AGD, de Lucca Schiavon L, Hohl A, van de Sande-Lee S. Flash glucose monitoring system in special situations. Arch Endocrinol Metab. 2022 Nov 17;66(6):883-894. Go to original source... Go to PubMed...
  17. Clubbs Coldron B, Coates V, Khamis A, MacRury S. Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues. J Diabetes Sci Technol. 2023 Mar;17(2):467-473. Go to original source... Go to PubMed...
  18. Buschur EO, Faulds E, Dungan K. CGM in the Hospital: Is It Ready for Prime Time? Curr Diab Rep. 2022 Sep;22(9):451-460. Go to original source... Go to PubMed...
  19. Irace C, Coluzzi S, Di Cianni G, et al. Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journey. Nutr Metab Cardiovasc Dis. 2023 Nov;33(11):2107-2118. Go to original source... Go to PubMed...
  20. Krakauer M, Botero JF, Lavalle-González FJ, et al. A review of flash glucose monitoring in type 2 diabetes. Diabetol Metab Syndr. 2021 Apr 9;13(1):42. Go to original source... Go to PubMed...
  21. Uhl S, Choure A, Rouse B, Loblack A, Reaven P. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2023 Nov 21:dgad652. Go to original source... Go to PubMed...
  22. Diez Alvarez S, Fellas A, Santos D, et al. The Clinical Impact of Flash Glucose Monitoring-a Digital Health App and Smartwatch Technology in Patients With Type 2 Diabetes: Scoping Review. JMIR Diabetes. 2023 Mar 15;8:e42389. Go to original source... Go to PubMed...
  23. Spanakis EK, Urrutia A, Galindo RJ, et al. Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial. Diabetes Care. 2022 Oct 1;45(10):2369-2375. Go to original source... Go to PubMed...
  24. Jancev M, Vissers TACM, Visseren FLJ, et al. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia. 2024 May;67(5):798-810. Go to original source... Go to PubMed...
  25. Wallia A, Umpierrez GE, Rushakoff RJ, et al. DTS Continuous Glucose Monitoring in the Hospital Panel. Consensus Statement on Inpatient Use of Continuous Glucose Monitoring. J Diabetes Sci Technol. 2017 Sep;11(5):1036-1044. Go to original source... Go to PubMed...
  26. Spanakis EK, Cook CB, Kulasa K, et al. A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials. J Diabetes Sci Technol. 2023 Nov;17(6):1527-1552. Go to original source... Go to PubMed...
  27. Avari P, Lumb A, Flanagan D, et al. Continuous Glucose Monitoring Within Hospital: A Scoping Review and Summary of Guidelines From the Joint British Diabetes Societies for Inpatient Care. J Diabetes Sci Technol. 2023 May;17(3):611-624. Go to original source... Go to PubMed...
  28. Nováková M, Kotvová V, Tománková, et al. Okamžité monitorování glukózy u seniorů hospitalizovaných na Geriatrické interní klinice 2. LF UK a FN Motol. Kasuistiky v diabetologii. 2024;22(1):25-27
  29. Kvapil M. Interpretace nových indexů. II. díl. VVD. 2024;9(2):19-21.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.